TY - JOUR AU - Osterberg, L. AU - Blaschke, T. PY - 2005 DA - 2005// TI - Adherence to medication JO - N Engl J Med VL - 353 UR - https://doi.org/10.1056/NEJMra050100 DO - 10.1056/NEJMra050100 ID - Osterberg2005 ER - TY - JOUR AU - Lasmar, L. AU - Camargos, P. AU - Champs, N. S. AU - Fonseca, M. T. AU - Fontes, M. J. AU - Ibiapina, C. PY - 2009 DA - 2009// TI - Adherence rate to inhaled corticosteroids and their impact on asthma control JO - Allergy VL - 64 UR - https://doi.org/10.1111/j.1398-9995.2008.01877.x DO - 10.1111/j.1398-9995.2008.01877.x ID - Lasmar2009 ER - TY - BOOK AU - Christensen, A. J. PY - 2004 DA - 2004// TI - Patient’s adherence to medical treatment regimens: bridging the gap between behavioural science and biomedicine. Current Perspectives in Psycology Series PB - Yale University Press CY - New Haven ID - Christensen2004 ER - TY - JOUR AU - Cutler, D. M. AU - Everett, W. PY - 2010 DA - 2010// TI - Thinking outside the pillbox--medication adherence as a priority for health care reform JO - N Engl J Med VL - 362 UR - https://doi.org/10.1056/NEJMp1002305 DO - 10.1056/NEJMp1002305 ID - Cutler2010 ER - TY - JOUR AU - Cutler, D. M. AU - Long, G. AU - Berndt, E. R. AU - Royer, J. AU - Fournier, A. A. AU - Sasser, A. PY - 2007 DA - 2007// TI - The value of antihypertensive drugs: a perspective on medical innovation JO - Health Aff (Millwood) VL - 26 UR - https://doi.org/10.1377/hlthaff.26.1.97 DO - 10.1377/hlthaff.26.1.97 ID - Cutler2007 ER - TY - JOUR AU - Reisacher, W. R. AU - Visaya, J. M. PY - 2013 DA - 2013// TI - Patient adherence to allergy immunotherapy JO - Curr Opin Otolaryngol Head Neck Surg VL - 21 UR - https://doi.org/10.1097/MOO.0b013e32835f8048 DO - 10.1097/MOO.0b013e32835f8048 ID - Reisacher2013 ER - TY - BOOK AU - Sabatè, E. PY - 2003 DA - 2003// TI - Adherence to long term therapies: evidence for action PB - World Health Organization CY - Geneva ID - Sabatè2003 ER - TY - JOUR AU - DiMatteo, M. R. PY - 2004 DA - 2004// TI - Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research JO - Med Care VL - 42 UR - https://doi.org/10.1097/01.mlr.0000114908.90348.f9 DO - 10.1097/01.mlr.0000114908.90348.f9 ID - DiMatteo2004 ER - TY - JOUR AU - Braido, F. AU - Baiardini, I. AU - Blasi, F. AU - Pawankar, R. AU - Canonica, G. W. PY - 2015 DA - 2015// TI - Adherence to asthma treatments: ‘we know, we intend, we advocate’ JO - Curr Opin Allergy Clin Immunol VL - 15 UR - https://doi.org/10.1097/ACI.0000000000000132 DO - 10.1097/ACI.0000000000000132 ID - Braido2015 ER - TY - JOUR AU - Chowdhury, R. AU - Khan, H. AU - Heydon, E. AU - Shroufi, A. AU - Fahimi, S. AU - Moore, C. PY - 2013 DA - 2013// TI - Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences JO - Eur Heart J VL - 34 UR - https://doi.org/10.1093/eurheartj/eht295 DO - 10.1093/eurheartj/eht295 ID - Chowdhury2013 ER - TY - JOUR AU - Kronish, I. M. AU - Ye, S. PY - 2013 DA - 2013// TI - Adherence to cardiovascular medications: lessons learned and future directions JO - Prog Cardiovasc Dis VL - 55 UR - https://doi.org/10.1016/j.pcad.2013.02.001 DO - 10.1016/j.pcad.2013.02.001 ID - Kronish2013 ER - TY - JOUR AU - Bender, D. G. PY - 2002 DA - 2002// TI - Overcoming barriers to nonadherence in asthma treatment JO - J Allergy Clin Immunol VL - 109 UR - https://doi.org/10.1067/mai.2002.124570 DO - 10.1067/mai.2002.124570 ID - Bender2002 ER - TY - JOUR AU - Sumino, K. AU - Cabana, M. D. PY - 2013 DA - 2013// TI - Medication adherence in asthma patients JO - Curr Opin Pulm Med VL - 19 UR - https://doi.org/10.1097/MCP.0b013e32835b117a DO - 10.1097/MCP.0b013e32835b117a ID - Sumino2013 ER - TY - JOUR AU - Gamble, J. AU - Stevenson, M. AU - McClean, E. AU - Heaney, L. G. PY - 2009 DA - 2009// TI - The prevalence of nonadherence in difficult asthma JO - Am J Respir Crit Care Med VL - 180 UR - https://doi.org/10.1164/rccm.200902-0166OC DO - 10.1164/rccm.200902-0166OC ID - Gamble2009 ER - TY - JOUR AU - Passalacqua, G. AU - Baiardini, I. AU - Senna, G. AU - Canonica, G. W. PY - 2013 DA - 2013// TI - Adherence to pharmacological treatment and specific immunotherapy in allergic rhinitis JO - Clin Exp Allergy VL - 43 UR - https://doi.org/10.1111/j.1365-2222.2012.04052.x DO - 10.1111/j.1365-2222.2012.04052.x ID - Passalacqua2013 ER - TY - JOUR AU - Busse, W. AU - Corren, J. AU - Lanier, B. Q. AU - McAlary, M. AU - Fowler-Taylor, A. AU - Cioppa, G. D. PY - 2001 DA - 2001// TI - Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma JO - J Allergy Clin Immunol VL - 108 UR - https://doi.org/10.1067/mai.2001.117880 DO - 10.1067/mai.2001.117880 ID - Busse2001 ER - TY - JOUR AU - Caminati, M. AU - Senna, G. AU - Chieco Bianchi, F. AU - Marchi, M. R. AU - Vianello, A. AU - Micheletto, C. PY - 2014 DA - 2014// TI - Omalizumab management beyond clinical trials: the added value of a network model JO - Pulm Pharmacol Ther VL - 29 UR - https://doi.org/10.1016/j.pupt.2014.01.007 DO - 10.1016/j.pupt.2014.01.007 ID - Caminati2014 ER - TY - JOUR AU - Lloyd, A. AU - Turk, F. AU - Leighton, T. AU - Canonica, G. W. PY - 2007 DA - 2007// TI - Psychometric evaluation of global evaluation of treatment effectiveness: a tool to assess patients with moderate-to-severe allergic asthma JO - J Med Econ VL - 10 UR - https://doi.org/10.3111/13696990701478856 DO - 10.3111/13696990701478856 ID - Lloyd2007 ER - TY - JOUR AU - Ayres, J. G. AU - Higgins, B. AU - Chilvers, E. R. AU - Ayre, G. AU - Blogg, M. AU - Fox, H. PY - 2004 DA - 2004// TI - Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with poorly controlled (moderate-to-severe) allergic asthma JO - Allergy VL - 59 UR - https://doi.org/10.1111/j.1398-9995.2004.00533.x DO - 10.1111/j.1398-9995.2004.00533.x ID - Ayres2004 ER - TY - JOUR AU - Hanania, N. A. AU - Alpan, O. AU - Hamilos, D. L. AU - Condemi, J. J. AU - Reyes-Rivera, I. AU - Zhu, J. PY - 2011 DA - 2011// TI - Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial JO - Ann Intern Med VL - 154 UR - https://doi.org/10.7326/0003-4819-154-9-201105030-00002 DO - 10.7326/0003-4819-154-9-201105030-00002 ID - Hanania2011 ER - TY - JOUR AU - Holgate, S. T. AU - Chuchalin, A. G. AU - Hebert, J. AU - Lötvall, J. AU - Persson, G. B. AU - Chung, K. F. PY - 2004 DA - 2004// TI - Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma JO - Clin Exp Allergy VL - 34 UR - https://doi.org/10.1111/j.1365-2222.2004.1916.x DO - 10.1111/j.1365-2222.2004.1916.x ID - Holgate2004 ER - TY - JOUR AU - Humbert, M. AU - Beasley, R. AU - Ayres, J. AU - Slavin, R. AU - Hebert, J. AU - Bousquet, J. PY - 2005 DA - 2005// TI - Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE JO - Allergy VL - 60 UR - https://doi.org/10.1111/j.1398-9995.2004.00772.x DO - 10.1111/j.1398-9995.2004.00772.x ID - Humbert2005 ER - TY - JOUR AU - Soler, M. AU - Matz, J. AU - Townley, R. AU - Buhl, R. AU - O’Brien, J. AU - Fox, H. PY - 2001 DA - 2001// TI - The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics JO - Eur Respir J VL - 18 UR - https://doi.org/10.1183/09031936.01.00092101 DO - 10.1183/09031936.01.00092101 ID - Soler2001 ER - TY - JOUR AU - Vignola, A. M. AU - Humbert, M. AU - Bousquet, J. AU - Boulet, L. P. AU - Hedgecock, S. AU - Blogg, M. PY - 2004 DA - 2004// TI - Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR JO - Allergy VL - 59 UR - https://doi.org/10.1111/j.1398-9995.2004.00550.x DO - 10.1111/j.1398-9995.2004.00550.x ID - Vignola2004 ER - TY - JOUR AU - Ancochea, J. AU - Chivato, T. AU - Casan, P. AU - Picado, C. AU - Herraez, L. AU - Casafont, J. PY - 2014 DA - 2014// TI - Profile of patients treated with omalizumab in routine clinical practice in Spain JO - Allergol Immunopathol (Madr) VL - 42 UR - https://doi.org/10.1016/j.aller.2012.10.010 DO - 10.1016/j.aller.2012.10.010 ID - Ancochea2014 ER - TY - JOUR AU - Barnes, N. AU - Menzies-Gow, A. AU - Mansur, A. H. AU - Spencer, D. AU - Percival, F. AU - Radwan, A. PY - 2013 DA - 2013// TI - Effectiveness of omalizumab in severe allergic asthma: a retrospective UK real-world study JO - J Asthma VL - 50 UR - https://doi.org/10.3109/02770903.2013.790419 DO - 10.3109/02770903.2013.790419 ID - Barnes2013 ER - TY - JOUR AU - Bavbek, S. AU - Aydin, O. AU - Kepil Özdemir, S. AU - Yilmaz, I. AU - Celik, G. E. AU - Demirel, Y. S. PY - 2010 DA - 2010// TI - Therapy with omalizumab in patients with severe persistent allergic asthma: a real life data in Turkey JO - Tuberk Toraks VL - 58 ID - Bavbek2010 ER - TY - JOUR AU - Braunstahl, G. J. AU - Chen, C. W. AU - Maykut, R. AU - Georgiou, P. AU - Peachey, G. AU - Bruce, J. PY - 2013 DA - 2013// TI - The eXpeRience registry: the ‘real-world’ effectiveness of omalizumab in allergic asthma JO - Respir Med VL - 107 UR - https://doi.org/10.1016/j.rmed.2013.04.017 DO - 10.1016/j.rmed.2013.04.017 ID - Braunstahl2013 ER - TY - JOUR AU - Brusselle, G. AU - Michils, A. AU - Louis, R. AU - Dupont, L. AU - Maele, B. AU - Delobbe, A. PY - 2009 DA - 2009// TI - “Real-life” effectiveness of omalizumab in patients with severe persistent allergic asthma: The PERSIST study JO - Respir Med VL - 103 UR - https://doi.org/10.1016/j.rmed.2009.06.014 DO - 10.1016/j.rmed.2009.06.014 ID - Brusselle2009 ER - TY - JOUR AU - Cazzola, M. AU - Camiciottoli, G. AU - Bonavia, M. AU - Gulotta, C. AU - Ravazzi, A. AU - Alessandrini, A. PY - 2010 DA - 2010// TI - Italian real-life experience of omalizumab JO - Respir Med VL - 104 UR - https://doi.org/10.1016/j.rmed.2010.04.013 DO - 10.1016/j.rmed.2010.04.013 ID - Cazzola2010 ER - TY - JOUR AU - Chen, H. AU - Eisner, M. D. AU - Haselkorn, T. AU - Trzaskoma, B. PY - 2013 DA - 2013// TI - Concomitant asthma medications in moderate-to-severe allergic asthma treated with omalizumab JO - Respir Med VL - 107 UR - https://doi.org/10.1016/j.rmed.2012.09.008 DO - 10.1016/j.rmed.2012.09.008 ID - Chen2013 ER - TY - JOUR AU - Eisner, M. D. AU - Zazzali, J. L. AU - Miller, M. K. AU - Bradley, M. S. AU - Schatz, M. PY - 2012 DA - 2012// TI - Longitudinal changes in asthma control with omalizumab: 2-year interim data from the EXCELS Study JO - J Asthma VL - 49 UR - https://doi.org/10.3109/02770903.2012.690477 DO - 10.3109/02770903.2012.690477 ID - Eisner2012 ER - TY - JOUR AU - Grimaldi-Bensouda, L. AU - Zureik, M. AU - Aubier, M. AU - Humbert, M. AU - Levy, J. AU - Benichou, J. PY - 2013 DA - 2013// TI - Does omalizumab make a difference to the real-life treatment of asthma exacerbations?: Results from a large cohort of patients with severe uncontrolled asthma JO - Chest VL - 143 UR - https://doi.org/10.1378/chest.12-1372 DO - 10.1378/chest.12-1372 ID - Grimaldi-Bensouda2013 ER - TY - JOUR AU - Korn, S. AU - Thielen, A. AU - Seyfried, S. AU - Taube, C. AU - Kornmann, O. AU - Buhl, R. PY - 2009 DA - 2009// TI - Omalizumab in patients with severe persistent allergic asthma in a real-life setting in Germany JO - Respir Med VL - 103 UR - https://doi.org/10.1016/j.rmed.2009.05.002 DO - 10.1016/j.rmed.2009.05.002 ID - Korn2009 ER - TY - JOUR AU - Lafeuille, M. H. AU - Dean, J. AU - Zhang, J. AU - Duh, M. S. AU - Gorsh, B. AU - Lefebvre, P. PY - 2012 DA - 2012// TI - Impact of omalizumab on emergency-department visits, hospitalizations, and corticosteroid use among patients with uncontrolled asthma JO - Ann Allergy Asthma Immunol VL - 109 UR - https://doi.org/10.1016/j.anai.2012.04.015 DO - 10.1016/j.anai.2012.04.015 ID - Lafeuille2012 ER - TY - JOUR AU - Maselli, D. J. AU - Singh, H. AU - Diaz, J. AU - Peters, J. I. PY - 2013 DA - 2013// TI - Efficacy of omalizumab in asthmatic patients with IgE levels above 700 IU/mL: a retrospective study JO - Ann Allergy Asthma Immunol VL - 110 UR - https://doi.org/10.1016/j.anai.2013.04.011 DO - 10.1016/j.anai.2013.04.011 ID - Maselli2013 ER - TY - JOUR AU - Molimard, M. AU - Blay, F. AU - Didier, A. AU - Gros, V. PY - 2008 DA - 2008// TI - Effectiveness of omalizumab (Xolair) in the first patients treated in real-life practice in France JO - Respir Med VL - 102 UR - https://doi.org/10.1016/j.rmed.2007.08.006 DO - 10.1016/j.rmed.2007.08.006 ID - Molimard2008 ER - TY - JOUR AU - Özgür, E. S. AU - Ozge, C. AU - Ilvan, A. AU - Nayci, S. A. PY - 2013 DA - 2013// TI - Assessment of long-term omalizumab treatment in patients with severe allergic asthma long-term omalizumab treatment in severe asthma JO - J Asthma VL - 50 UR - https://doi.org/10.3109/02770903.2013.792348 DO - 10.3109/02770903.2013.792348 ID - Özgür2013 ER - TY - JOUR AU - Tzortzaki, E. G. AU - Georgiou, A. AU - Kampas, D. AU - Lemessios, M. AU - Markatos, M. AU - Adamidi, T. PY - 2012 DA - 2012// TI - Long-term omalizumab treatment in severe allergic asthma: the South-Eastern Mediterranean “real-life” experience JO - Pulm Pharmacol Ther VL - 25 UR - https://doi.org/10.1016/j.pupt.2011.11.004 DO - 10.1016/j.pupt.2011.11.004 ID - Tzortzaki2012 ER - TY - JOUR AU - Vennera Mdel, C. AU - Perez De Llano, L. AU - Bardagi, S. AU - Ausin, P. AU - Sanjuas, C. AU - Gonzalez, H. PY - 2012 DA - 2012// TI - Omalizumab therapy in severe asthma: experience from the Spanish registry--some new approaches JO - J Asthma VL - 49 UR - https://doi.org/10.3109/02770903.2012.668255 DO - 10.3109/02770903.2012.668255 ID - Vennera Mdel2012 ER - TY - JOUR AU - Vieira, T. AU - Oliveira, J. F. AU - Graca Castel-Branco, M. PY - 2014 DA - 2014// TI - Short and long-term quality of life and asthma control with omalizumab therapy in a real life setting in Portugal JO - Allergol Immunopathol (Madr) VL - 42 UR - https://doi.org/10.1016/j.aller.2012.07.006 DO - 10.1016/j.aller.2012.07.006 ID - Vieira2014 ER - TY - JOUR AU - Wittchen, H. U. AU - Muhlig, S. AU - Klotsche, J. AU - Buhl, R. AU - Kardos, P. AU - Ritz, T. PY - 2012 DA - 2012// TI - Omalizumab versus ‘usual care’: results from a naturalistic longitudinal study in routine care JO - Int Arch Allergy Immunol VL - 159 UR - https://doi.org/10.1159/000335382 DO - 10.1159/000335382 ID - Wittchen2012 ER - TY - JOUR AU - Wu, A. C. AU - Butler, M. G. AU - Li, L. AU - Fung, V. AU - Kharbanda, E. O. AU - Larkin, E. K. PY - 2015 DA - 2015// TI - Primary adherence to controller medications for asthma is poor JO - Ann Am Thorac Soc VL - 12 UR - https://doi.org/10.1513/AnnalsATS.201410-459OC DO - 10.1513/AnnalsATS.201410-459OC ID - Wu2015 ER - TY - JOUR AU - Janson, S. L. AU - Solari, P. G. AU - Trzaskoma, B. AU - Chen, H. AU - Haselkorn, T. AU - Zazzali, J. L. PY - 2015 DA - 2015// TI - Omalizumab adherence in an observational study of patients with moderate to severe allergic asthma JO - Ann Allergy Asthma Immunol VL - 114 UR - https://doi.org/10.1016/j.anai.2015.04.010 DO - 10.1016/j.anai.2015.04.010 ID - Janson2015 ER - TY - JOUR AU - Broder, M. S. AU - Chang, E. Y. AU - Ory, C. AU - Kamath, T. AU - Sapra, S. PY - 2009 DA - 2009// TI - Adherence and persistence with omalizumab and fluticasone/salmeterol within a managed care population JO - Allergy Asthma Proc VL - 30 UR - https://doi.org/10.2500/aap.2009.30.3190 DO - 10.2500/aap.2009.30.3190 ID - Broder2009 ER - TY - JOUR AU - Hendeles, L. AU - Khan, Y. R. AU - Shuster, J. J. AU - Chesrown, S. E. AU - Abu-Hasan, M. PY - 2015 DA - 2015// TI - Omalizumab therapy for asthma patients with poor adherence to inhaled corticosteroid therapy JO - Ann Allergy Asthma Immunol VL - 114 UR - https://doi.org/10.1016/j.anai.2014.10.012 DO - 10.1016/j.anai.2014.10.012 ID - Hendeles2015 ER - TY - JOUR AU - Zuberbier, T. AU - Bachert, C. AU - Bousquet, P. J. AU - Passalacqua, G. AU - Walter Canonica, G. AU - Merk, H. PY - 2010 DA - 2010// TI - GA(2) LEN/EAACI pocket guide for allergen-specific immunotherapy for allergic rhinitis and asthma JO - Allergy VL - 65 UR - https://doi.org/10.1111/j.1398-9995.2010.02474.x DO - 10.1111/j.1398-9995.2010.02474.x ID - Zuberbier2010 ER - TY - JOUR AU - Senna, G. AU - Caminati, M. AU - Lockey, R. F. PY - 2015 DA - 2015// TI - Allergen immunotherapy adherence in the real world: How bad is it and how can it be improved? JO - Curr Treat Options Allergy VL - 2 UR - https://doi.org/10.1007/s40521-014-0037-6 DO - 10.1007/s40521-014-0037-6 ID - Senna2015 ER - TY - JOUR AU - Schlender, A. AU - Alperin, P. E. AU - Grossman, H. L. AU - Sutherland, E. R. PY - 2012 DA - 2012// TI - Modeling the impact of increased adherence to asthma therapy JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0051139 DO - 10.1371/journal.pone.0051139 ID - Schlender2012 ER - TY - JOUR AU - Saturni, S. AU - Bellini, F. AU - Braido, F. AU - Paggiaro, P. AU - Sanduzzi, A. AU - Scichilone, N. PY - 2014 DA - 2014// TI - Randomized Controlled Trials and real life studies. Approaches and methodologies: a clinical point of view JO - Pulm Pharmacol Ther VL - 27 UR - https://doi.org/10.1016/j.pupt.2014.01.005 DO - 10.1016/j.pupt.2014.01.005 ID - Saturni2014 ER - TY - JOUR AU - Caminati, M. AU - Senna, G. AU - Guerriero, M. AU - Dama, A. R. AU - Chieco-Bianchi, F. AU - Stefanizzi, G. PY - 2015 DA - 2015// TI - Omalizumab for severe allergic asthma in clinical trials and real-life studies: what we know and what we should address JO - Pulm Pharmacol Ther VL - 31 UR - https://doi.org/10.1016/j.pupt.2015.01.006 DO - 10.1016/j.pupt.2015.01.006 ID - Caminati2015 ER - TY - STD TI - European Medicines Agency; Xolair: EPAR - Product Information. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000606/human_med_001162.jsp&mid=WC0b01ac058001d124. Accessed 20 June 2015. UR - http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000606/human_med_001162.jsp&mid=WC0b01ac058001d124 ID - ref52 ER - TY - JOUR AU - Domingo, C. AU - Pomares, X. AU - Angril, N. AU - Rudi, N. AU - Amengual, M. J. AU - Mirapeix, R. M. PY - 2013 DA - 2013// TI - Effectiveness of omalizumab in non-allergic severe asthma JO - J Biol Regul Homeost Agents VL - 27 ID - Domingo2013 ER - TY - JOUR AU - Arron, J. R. AU - Choy, D. F. AU - Scheerens, H. AU - Matthews, J. G. PY - 2013 DA - 2013// TI - Noninvasive biomarkers that predict treatment benefit from biologic therapies in asthma JO - Ann Am Thorac Soc VL - 10 UR - https://doi.org/10.1513/AnnalsATS.201303-047AW DO - 10.1513/AnnalsATS.201303-047AW ID - Arron2013 ER - TY - JOUR AU - Bartminski, G. AU - Crossley, M. AU - Turcanu, V. PY - 2015 DA - 2015// TI - Novel biomarkers for asthma stratification and personalized therapy JO - Expert Rev Mol Diagn VL - 15 UR - https://doi.org/10.1586/14737159.2015.988613 DO - 10.1586/14737159.2015.988613 ID - Bartminski2015 ER - TY - JOUR AU - Caffarelli, C. AU - Calcinai, E. AU - Rinaldi, L. AU - Povesi Dascola, C. AU - Terracciano, L. AU - Corradi, M. PY - 2012 DA - 2012// TI - Hydrogen peroxide in exhaled breath condensate in asthmatic children during acute exacerbation and after treatment JO - Respiration VL - 84 UR - https://doi.org/10.1159/000341969 DO - 10.1159/000341969 ID - Caffarelli2012 ER - TY - JOUR AU - Caffarelli, C. AU - Dascola, C. P. AU - Peroni, D. AU - Ricò, S. AU - Stringari, G. AU - Varini, M. AU - Folesani, G. AU - Corradi, M. PY - 2014 DA - 2014// TI - Airway acidification in childhood asthma exacerbations JO - Allergy Asthma Proc VL - 35 UR - https://doi.org/10.2500/aap.2014.35.3740 DO - 10.2500/aap.2014.35.3740 ID - Caffarelli2014 ER - TY - JOUR AU - Hilvering, B. AU - Pavord, I. D. PY - 2015 DA - 2015// TI - What goes up must come down: biomarkers and novel biologicals in severe asthma JO - Clin Exp Allergy VL - 45 UR - https://doi.org/10.1111/cea.12500 DO - 10.1111/cea.12500 ID - Hilvering2015 ER - TY - JOUR AU - Fajt, M. L. AU - Wenzel, S. E. PY - 2015 DA - 2015// TI - Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care JO - J Allergy Clin Immunol VL - 135 UR - https://doi.org/10.1016/j.jaci.2014.12.1871 DO - 10.1016/j.jaci.2014.12.1871 ID - Fajt2015 ER - TY - JOUR AU - Senna, G. AU - Caminati, M. AU - Canonica, G. W. PY - 2013 DA - 2013// TI - Safety and tolerability of sublingual immunotherapy in clinical trials and real life JO - Curr Opin Allergy Clin Immunol VL - 13 UR - https://doi.org/10.1097/ACI.0000000000000007 DO - 10.1097/ACI.0000000000000007 ID - Senna2013 ER - TY - JOUR AU - Battaglia, S. AU - Basile, M. AU - Spatafora, M. AU - Scichilone, N. PY - 2015 DA - 2015// TI - Are asthmatics enrolled in randomized trials representative of real-life outpatients? JO - Respiration VL - 89 UR - https://doi.org/10.1159/000375314 DO - 10.1159/000375314 ID - Battaglia2015 ER - TY - JOUR AU - Eakin, M. N. AU - Rand, C. S. PY - 2012 DA - 2012// TI - Improving patient adherence with asthma self-management practices: what works? JO - Ann Allergy Asthma Immunol VL - 109 UR - https://doi.org/10.1016/j.anai.2012.06.009 DO - 10.1016/j.anai.2012.06.009 ID - Eakin2012 ER - TY - JOUR AU - Shams, M. R. AU - Fineman, S. M. PY - 2014 DA - 2014// TI - Asthma adherence: how can we help our patients do it better? JO - Ann Allergy Asthma Immunol VL - 112 UR - https://doi.org/10.1016/j.anai.2013.10.013 DO - 10.1016/j.anai.2013.10.013 ID - Shams2014 ER -